Products
AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$10/mo
Lower than 80% of peersNiche median $29/mo
Creators
Artur Arutyunov
@realexpowizard· 2 followers
Launched
11mo ago
2025-12-10 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
X accounts@realexpowizard

  • Launched on Product HuntLaunch

    Kill data entry. Win more deals.

    Dec 10, 2025 · 11mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2024-09-06

KeywordMonthly volume
a2pwizard490

Traffic data: Vaneform

Pricing

Monthly User License
$10/mo
Unlimited scans
Annual User License
$8.33 (Billed Annually)

Trial: None · 1 paid tier ($10) · Observed 2026-11-07 · Source page

Entry price $10/mo, Lower than 80% of peers; “Lead Databases & Enrichment” median is $29/mo.View pricing benchmark

Pages & changes

Tracked since 2025-12-10

Key pages

Weekly snapshots
expowizard.com/ Snapshot 2026-11-08

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does ExpoWizard cost?
Monthly User License: $10/mo; Annual User License: $8.33 (Billed Annually). Observed 2026-11-07. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does ExpoWizard get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is ExpoWizard and what platforms does it support?
ExpoWizard is catalogued under Lead Databases & Enrichment: Ready for Your Next Event?. Supported platforms: Mobile App.

Related products in this category

Sales / Lead Databases & Enrichment

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.